Wednesday, December 7, 2016

AIDS Drug Assistance Programs in the Age of Trump's "Make America Great Again"

›
By: Brandon M. Macsata, CEO, ADAP Advocacy Association The ADAP Advocacy Association does not engage in any political activities, politic...
Friday, October 28, 2016

Why HIV Medical Treatment Guidelines Matter

›
By: Brandon M. Macsata, CEO, ADAP Advocacy Association As with all chronic diseases and conditions the approved medical treatment guidelin...
1 comment:
Friday, October 7, 2016

How North Carolina Legalized Syringe Exchange Programs

›
By:  Tessie Castillo,  Communications and Advocacy Coordinator,  North Carolina Harm Reduction Coalition (NCHRC) In July 2016, North ...
1 comment:
Thursday, September 29, 2016

Magnifying How ADAP Provides Treatment For People Living With HIV/AIDS

›
By: Brandon M. Macsata, CEO, ADAP Advocacy Association On September 23rd and 24th, " Magnifying How ADAP Provides Treatment For Peopl...
Friday, September 16, 2016

Annual National Monitoring Report on HIV/HCV Co-Infection

›
By: Marcus J. Hopkins, Project Director, HIV/HCV Co-Infection Watch, Community Access National Network (CANN) The ADAP Advocacy Associatio...
Thursday, September 1, 2016

Californication and the Battle Over Drug Pricing

›
By: Brandon M. Macsata, CEO, ADAP Advocacy Association POLITICO reported this week that California's controversial Prop 61, entitled ...
Thursday, August 25, 2016

Mandating Treatment for HIV-Related Lipodystrophy: The Massachusetts experience and a call for national action

›
By: Ben Klein, Senior Attorney and AIDS Law Project Director, GLBTQ Legal Advocates & Defenders There is a debilitating and disfigurin...
1 comment: